Annual Drug Patent Expirations for TRI-LUMA
Tri-luma is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has twenty-six patent family members in eighteen countries.
The generic ingredient in TRI-LUMA is fluocinolone acetonide; hydroquinone; tretinoin. One supplier is listed for this compound. Additional details are available on the fluocinolone acetonide; hydroquinone; tretinoin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
